LATIN AMERICA CRISPR MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

LATIN AMERICA CRISPR MARKET 2021-2028

Market by Product, Application, Industry Verticals, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s report implies that the Latin American CRISPR market is expected to surge at a compound annual growth rate of 18.82% during the predicted period 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries scrutinized in this market include:

•        Brazil

•        Mexico

•        Rest of Latin America

In the region, farmers are partnering with scientists to create new crop varieties using gene-editing techniques like CRISPR-Cas9. This step is to help the region realize its potential in the food production industry. Moreover, these partnerships are the extension of the work performed by farmers over the years. Moreover, the new research is focused mainly on countries that are open to adopting gene-editing technologies. However, the region gains a small percentage of the CRISPR market due to a lack of technological development. Nevertheless, the steady growth in gene-editing is likely to create opportunities for the CRISPR market.

Among the countries, Brazil dominates the CRISPR market, with researchers contributing to the majority of the growth. For instance, the phylogenetic analysis of the Brazilian genome showed that the strains share a larger number of SNPs than other ST277 genomes. Additionally, the Brazilian endemic clone pseudomonas aeruginosa ST277 contains vital antibiotic resistance determinants, emphasizing the gene coding for SPM-1. Thus, as mentioned above, these factors are expected to support the development of the CRISPR market across Brazil in the upcoming years.

CRISPR Therapeutics AG is a gene-editing company engaged in the development of transformative gene-based medicines to treat various chronic conditions. Its product line includes CTX001, an autologous CRISPR gene-edited hematopoietic stem cell therapy for ?-thalassemia and sickle cell disease patients. Additionally, the company offers solutions relating to hemoglobinopathies, immuno-oncology, regenerative medicine, and In-vivo. CRISPR Therapeutics offers products across multiple regions, including Latin America. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. LATIN AMERICA CRISPR MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON CRISPR MARKET

2.2. KEY INSIGHTS

2.2.1. INDUSTRIAL BIOTECH IS THE FASTEST GROWING INDUSTRY VERTICAL

2.2.2. REWRITING OF GENETIC DISORDERS THROUGH GENOME SURGERY

2.2.3. INCREASING USAGE OF PROSPECTIVE APPLICATIONS OF CRISPR TECHNOLOGY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. LEGAL & REGULATORY OUTLOOK

2.7. PATENT OUTLOOK

2.8. FUNDING OUTLOOK

2.9. KEY IMPACT ANALYSIS

2.9.1. COST

2.9.2. ACCURACY

2.9.3. EASY TO USE

2.10. KEY MARKET STRATEGIES

2.10.1. ACQUISITIONS

2.10.2. PRODUCT LAUNCHES

2.10.3. CONTRACTS & PARTNERSHIPS

2.10.4. BUSINESS EXPANSIONS & DIVESTITURES

2.11. MARKET DRIVERS

2.11.1. GROWING LIFESTYLE-ORIENTED DISEASES

2.11.2. SURGING PREVALENCE OF GENETIC DISEASES

2.12. MARKET CHALLENGES

2.12.1. GROWING ETHICAL ISSUES REGARDING TECHNOLOGY USE

2.12.2. LIKELY MISUSE OF GENE-EDITING TOOL

2.12.3. ABSENCE OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES

2.13. MARKET OPPORTUNITIES

2.13.1. ADVANCEMENTS IN GENE-BASED THERAPY IN THE AGRICULTURAL SECTOR

2.13.2. INCREASED NEED FOR CLINICAL TRIALS

2.13.3. RISE IN AWARENESS ABOUT GENE THERAPEUTICS

3. LATIN AMERICA CRISPR MARKET OUTLOOK - BY PRODUCT

3.1. PLASMIDS

3.2. VECTORS

3.3. PROTEINS

3.4. DESIGNING TOOLS

3.5. GRNA

3.6. CONTROL KITS

3.7. LIBRARY

3.8. OTHER PRODUCTS

4. LATIN AMERICA CRISPR MARKET OUTLOOK - BY APPLICATION

4.1. GENOME EDITING/GENETIC ENGINEERING

4.2. CRISPR PLASMID

4.3. HUMAN STEM CELLS

4.4. GRNA DATABASE/GENE LIBRARY

4.5. CELL LINE ENGINEERING

5. LATIN AMERICA CRISPR MARKET OUTLOOK - BY INDUSTRY VERTICALS

5.1. THERAPEUTICS AND DRUG DISCOVERY

5.2. BIOLOGICAL RESEARCH

5.3. AGRICULTURAL BIOTECH

5.4. INDUSTRIAL BIOTECH

6. LATIN AMERICA CRISPR MARKET – REGIONAL OUTLOOK

6.1. BRAZIL

6.2. MEXICO

6.3. REST OF LATIN AMERICA

7. COMPETITIVE LANDSCAPE

7.1. ADDGENE

7.2. CARIBOU BIOSCIENCES INC

7.3. CELLECTIS BIORESEARCH SAS

7.4. CRISPR THERAPEUTICS AG

7.5. EDITAS MEDICINE

7.6. GENSCRIPT

7.7. HORIZON DISCOVERY GROUP

7.8. INTEGRATED DNA TECHNOLOGIES

7.9. INTELLIA THERAPEUTICS

7.10. LONZA GROUP LTD

7.11. NEW ENGLAND BIOLABS

7.12. NOVARTIS INTERNATIONAL AG

7.13. ORIGENE TECHNOLOGIES INC

7.14. PRECISION BIOSCIENCES

7.15. SYNTHEGO CORPORATION

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: LATIN AMERICA CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)      

TABLE 2: VENDOR SCORECARD        

TABLE 3: REGULATORY FRAMEWORK         

TABLE 4: FUNDING OUTLOOK OF PUBLIC COMPANIES  

TABLE 5: FUNDING OUTLOOK OF PRIVATE COMPANIES

TABLE 6: FUNDING OUTLOOK OF GOVERNMENT ORGANIZATIONS   

TABLE 7: LATIN AMERICA CRISPR MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)      

TABLE 8: LATIN AMERICA CRISPR MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 9: LATIN AMERICA CRISPR MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)      

TABLE 10: LATIN AMERICA CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)     

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX       

FIGURE 2: FUNDING SCENARIO SHARE, BY TYPE OF COMPANIES/ORGANIZATION         

FIGURE 3: KEY IMPACT ANALYSIS     

FIGURE 4: LATIN AMERICA CRISPR MARKET, BY PRODUCT, 2020 & 2028 (IN %)    

FIGURE 5: LATIN AMERICA CRISPR MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)   

FIGURE 6: LATIN AMERICA CRISPR MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)    

FIGURE 7: LATIN AMERICA CRISPR MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)   

FIGURE 8: LATIN AMERICA CRISPR MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)      

FIGURE 9: LATIN AMERICA CRISPR MARKET, BY GRNA, 2021-2028 (IN $ MILLION)

FIGURE 10: LATIN AMERICA CRISPR MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)           

FIGURE 11: LATIN AMERICA CRISPR MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)    

FIGURE 12: LATIN AMERICA CRISPR MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)      

FIGURE 13: LATIN AMERICA CRISPR MARKET, BY APPLICATION, 2020 & 2028 (IN %)       

FIGURE 14: LATIN AMERICA CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)      

FIGURE 15: LATIN AMERICA CRISPR MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)      

FIGURE 16: LATIN AMERICA CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)      

FIGURE 17: LATIN AMERICA CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)          

FIGURE 18: LATIN AMERICA CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)      

FIGURE 19: LATIN AMERICA CRISPR MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)          

FIGURE 20: LATIN AMERICA CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 21: LATIN AMERICA CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)      

FIGURE 22: LATIN AMERICA CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)   

FIGURE 23: LATIN AMERICA CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)      

FIGURE 24: LATIN AMERICA CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)           

FIGURE 25: BRAZIL CRISPR MARKET 2021-2028 (IN $ MILLION)

FIGURE 26: MEXICO CRISPR MARKET 2021-2028 (IN $ MILLION)          

FIGURE 27: REST OF LATIN AMERICA CRISPR MARKET 2021-2028 (IN $ MILLION)  

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying